Categories rss-es Update on Risk of Type III Endoleaks with Use of Endologix AFX Endovascular AAA Graft Systems – FDA Safety CommunicationMurilo Freitas - 05:00, 5 de diciembre de 20221,857 0 Do not routinely use AFX2 endovascular grafts for patients with abdominal aortic aneurysms. http://www.fda.gov/medical-devices/safety-communications/update-risk-type-iii-endoleaks-use-endologix-afx-endovascular-aaa-graft-systems-fda-safety 0